[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354368-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354368-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","in-silico-analysis-suggests-ell2-as-a-survival-associated-cross-tissue-biomarker-in-gastric-cancer","In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer","","Integrative bioinformatics analysis identifies ELL2 as a survival-associated cross-tissue biomarker in gastric cancer, addressing the need for clearer prognostic indicators in a globally challenging disease. Gene expression datasets from blood, tissue, and saliva were retrieved from GEO and analyzed through differential expression and enrichment analyses, with survival assessment using Kaplan-Meier Plotter. Differentially expressed genes were validated in TCGA, and DEGs-linked lncRNAs and microRNAs were explored. ELL2 showed reduced expression across all specimens and correlated with immune system activity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/in-silico-analysis-suggests-ell2-as-a-survival-associated-cross-tissue-biomarker-in-gastric-cancer/354368/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/in-silico-analysis-suggests-ell2-as-a-survival-associated-cross-tissue-biomarker-in-gastric-cancer/354368.png","ImageObject",300,407,{"name":42,"@type":43},"Kurz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main aim of the study on gastric cancer biomarkers?","Question",{"text":63,"@type":64},"The study aimed to identify prognostic biomarkers by integrating bioinformatics analyses in gastric cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the datasets and key genes analyzed and validated?",{"text":68,"@type":64},"Gene expression datasets for blood, tissue, and saliva were downloaded from GEO. Differentially expressed genes were identified and evaluated with enrichment analysis and Kaplan-Meier survival analysis, and the DEGs were validated using TCGA.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the study conclude about ELL2?",{"text":72,"@type":64},"ELL2 is downregulated across blood, tissue, and saliva samples and shows a significant association with patient survival, along with correlation to immune system activity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354368,1791263691,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer  \nCancer Biomarkers Volume 43: 1–16 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/18758592261463305](DOI: 10.1177/18758592261463305)[ ](DOI: 10.1177/18758592261463305)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nKiarash Zare1, Zahra Salehi2,3, Ali Reza Morovat4, Ali Aghajani5,6, Pardis Mohammadi Pour7, Ali Ghanbariasad8, and Mohammad Mehdi Naghizadeh9   \nAbstract  \nBackground: The main aim of this study is to identify prognostic biomarkers through integrating bioinformatics analysis in gastric cancer, which is a significant global health challenge. Methods: Gene expression datasets related to blood, tissue, and saliva in gastric cancer were downloaded from the Gene Expression Omnibus (GEO) database and analyzed. The bioinformatics approaches included the identification of differentially expressed genes (DEGs) and enrichment analysis, as well as Kaplan-Meier Plotter survival analysis. The DEGs were also validated through The Cancer Genome Atlas (TCGA) database. Additionally, DEGs-associated lncRNAs and microRNAs were identified. Subsequently, Tumor and Immune System Interaction Database (TISIDB) was utilized to examine the correlation of the genes of interest with immune and molecular subtypes. Results: Twenty-six common DEGs were identified across blood, tissue, and saliva samples. Among them, 17 genes showed significant expression based on TCGA data. RAB23, LOX, ELL2, ELK3, CENPF, CD44, ANP32E, AKR1C2, and SMAD5 displayed significant association with patient survival. Particularly, ELL2 exhibit decreased expression in all specimens. The results indicated that ELL2 has a significant correlation with the immune system. The ELL2 gene regulates immune cell functions in gastric cancer, potentially influencing cancer immune responses, and tumor progression. Conclusion: ELL2 downregulated expression and its correlation with survival across blood, tissue, and saliva samples using bioinformatics analysis underscores the necessity of more investigation to fully comprehend its function in cancer immunology.  \nKeywords  \ngastric cancer, gene expression profiling, bioinformatics analysis, ELL2, biomarker, differentially express genes  \nReceived: 2 May 2025; Revised: 21 February 2026; Accepted: 7 June 2026  \n1Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran  \n2Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran  \n3Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran  \n4Systems Biology Research Group, Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran  \n5School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran  \n6Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Centre, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n7Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran  \n8Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran 9Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran  \nCorresponding author:  \nMohammad Mehdi Naghizadeh, Avesina sq. Noncommunicable Disease Research Center, Fasa University of Medical Sciences, Fasa Pobox: 74616-86688, Iran.  \n[Email:](Email: mmnaghi2@yahoo.com)[ mmnaghi2@yahoo.com](Email: mmnaghi2@yahoo.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the ","cbCaiua8oLHAH6ye","https://ap.wps.com/l/cbCaiua8oLHAH6ye","pdf",4511668,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the main aim of the study on gastric cancer biomarkers?\",\"answer\":\"The study aimed to identify prognostic biomarkers by integrating bioinformatics analyses in gastric cancer.\"},{\"question\":\"How were the datasets and key genes analyzed and validated?\",\"answer\":\"Gene expression datasets for blood, tissue, and saliva were downloaded from GEO. Differentially expressed genes were identified and evaluated with enrichment analysis and Kaplan-Meier survival analysis, and the DEGs were validated using TCGA.\"},{\"question\":\"What does the study conclude about ELL2?\",\"answer\":\"ELL2 is downregulated across blood, tissue, and saliva samples and shows a significant association with patient survival, along with correlation to immune system activity.\"}]","In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer | PDF",1790110339,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc00c1e7d8ad9e6dc0d9c00799af870e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c7e7de612da47d79f1acb8e48882b2a.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/526c5945465782af218ebe3ec4aae8db.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96f169dce9aae5513a1c3f9ed3b94a0a.webp",980,1306]